LLY logo

Eli Lilly and Company (LLY) Operating profit

annual operating profit:

$17.04B+$6.25B(+57.96%)
December 31, 2024

Summary

  • As of today (April 12, 2025), LLY annual operating income is $17.04 billion, with the most recent change of +$6.25 billion (+57.96%) on December 31, 2024.
  • During the last 3 years, LLY annual operating profit has risen by +$9.11 billion (+114.80%).
  • LLY annual operating profit is now at all-time high.

Performance

LLY Operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLLYincome statement metrics

quarterly operating profit:

$5.68B+$1.25B(+28.13%)
December 31, 2024

Summary

  • As of today (April 12, 2025), LLY quarterly operating income is $5.68 billion, with the most recent change of +$1.25 billion (+28.13%) on December 31, 2024.
  • Over the past year, LLY quarterly operating profit has stayed the same.
  • LLY quarterly operating profit is now at all-time high.

Performance

LLY quarterly operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLLYincome statement metrics

TTM operating profit:

$17.27B+$2.14B(+14.16%)
December 31, 2024

Summary

  • As of today (April 12, 2025), LLY TTM operating income is $17.27 billion, with the most recent change of +$2.14 billion (+14.16%) on December 31, 2024.
  • Over the past year, LLY TTM operating profit has stayed the same.
  • LLY TTM operating profit is now at all-time high.

Performance

LLY TTM operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLLYincome statement metrics

Operating profit Formula

Operating Profit = Gross Profit − Operating Expenses

LLY Operating profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+58.0%0.0%0.0%
3 y3 years+114.8%+231.3%+118.8%
5 y5 years+184.0%+231.3%+118.8%

LLY Operating profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+114.8%at high+231.3%at high+118.8%
5 y5-yearat high+184.0%at high+285.4%at high+173.3%
alltimeall timeat high+2763.9%at high+332.9%at high+8590.9%

Eli Lilly and Company Operating profit History

DateAnnualQuarterlyTTM
Dec 2024
$17.04B(+58.0%)
$5.68B(+28.1%)
$17.27B(+14.2%)
Sep 2024
-
$4.43B(+0.4%)
$15.13B(+7.1%)
Jun 2024
-
$4.42B(+61.5%)
$14.12B(+17.3%)
Mar 2024
-
$2.74B(-22.7%)
$12.04B(+9.3%)
Dec 2023
$10.79B(+24.7%)
$3.54B(+3.3%)
$11.02B(+10.6%)
Sep 2023
-
$3.43B(+46.5%)
$9.97B(+17.4%)
Jun 2023
-
$2.34B(+36.4%)
$8.49B(+7.5%)
Mar 2023
-
$1.71B(-31.1%)
$7.89B(-10.7%)
Dec 2022
$8.65B(+9.1%)
$2.49B(+27.9%)
$8.84B(-0.5%)
Sep 2022
-
$1.95B(+11.5%)
$8.89B(-2.1%)
Jun 2022
-
$1.74B(-34.5%)
$9.07B(+2.6%)
Mar 2022
-
$2.66B(+5.2%)
$8.84B(+11.5%)
Dec 2021
$7.93B(+11.7%)
$2.53B(+18.8%)
$7.93B(+1.9%)
Sep 2021
-
$2.13B(+40.5%)
$7.79B(+8.9%)
Jun 2021
-
$1.52B(-13.4%)
$7.15B(+0.6%)
Mar 2021
-
$1.75B(-26.5%)
$7.11B(+0.1%)
Dec 2020
$7.10B(+18.4%)
$2.39B(+59.7%)
$7.10B(+12.4%)
Sep 2020
-
$1.49B(+1.3%)
$6.32B(-1.0%)
Jun 2020
-
$1.47B(-15.6%)
$6.39B(-1.5%)
Mar 2020
-
$1.75B(+9.0%)
$6.49B(+8.1%)
Dec 2019
$6.00B(-0.4%)
$1.60B(+2.8%)
$6.00B(+1.9%)
Sep 2019
-
$1.56B(-0.8%)
$5.88B(+1.4%)
Jun 2019
-
$1.57B(+24.7%)
$5.80B(-1.3%)
Mar 2019
-
$1.26B(-15.3%)
$5.88B(-2.4%)
Dec 2018
$6.03B(+41.8%)
$1.49B(+0.8%)
$6.03B(+17.3%)
Sep 2018
-
$1.48B(-10.3%)
$5.14B(+5.4%)
Jun 2018
-
$1.65B(+17.0%)
$4.88B(+7.4%)
Mar 2018
-
$1.41B(+134.5%)
$4.54B(+6.9%)
Dec 2017
$4.25B(+9.8%)
$600.80M(-50.6%)
$4.25B(-9.6%)
Sep 2017
-
$1.22B(-7.4%)
$4.70B(+5.1%)
Jun 2017
-
$1.31B(+17.6%)
$4.47B(+8.0%)
Mar 2017
-
$1.12B(+6.1%)
$4.14B(+7.0%)
Dec 2016
$3.87B(+7.8%)
$1.05B(+6.6%)
$3.87B(+8.7%)
Sep 2016
-
$989.00M(+0.8%)
$3.56B(-0.4%)
Jun 2016
-
$981.30M(+15.8%)
$3.58B(+0.7%)
Mar 2016
-
$847.20M(+13.9%)
$3.55B(-1.2%)
Dec 2015
$3.59B(+7.9%)
$743.80M(-25.9%)
$3.59B(-3.7%)
Sep 2015
-
$1.00B(+5.1%)
$3.73B(+9.1%)
Jun 2015
-
$955.40M(+7.4%)
$3.42B(+2.1%)
Mar 2015
-
$889.20M(+0.7%)
$3.35B(+0.7%)
Dec 2014
$3.33B(-40.0%)
$882.60M(+27.3%)
$3.33B(-3.2%)
Sep 2014
-
$693.30M(-21.8%)
$3.44B(-19.8%)
Jun 2014
-
$886.60M(+2.4%)
$4.29B(-13.7%)
Mar 2014
-
$866.20M(-12.8%)
$4.97B(-10.4%)
Dec 2013
$5.55B(+10.6%)
$993.30M(-35.7%)
$5.55B(-4.7%)
Sep 2013
-
$1.54B(-1.4%)
$5.82B(+7.5%)
Jun 2013
-
$1.57B(+8.5%)
$5.42B(+7.2%)
Mar 2013
-
$1.44B(+13.8%)
$5.05B(+0.8%)
Dec 2012
$5.02B(-20.6%)
$1.27B(+11.3%)
$5.02B(+0.6%)
Sep 2012
-
$1.14B(-5.2%)
$4.98B(-8.6%)
Jun 2012
-
$1.20B(-14.4%)
$5.45B(-8.7%)
Mar 2012
-
$1.41B(+13.7%)
$5.97B(-5.4%)
Dec 2011
$6.32B(-6.7%)
$1.24B(-23.3%)
$6.32B(-4.4%)
Sep 2011
-
$1.61B(-6.4%)
$6.61B(-2.1%)
Jun 2011
-
$1.72B(-1.6%)
$6.75B(-0.9%)
Mar 2011
-
$1.75B(+14.5%)
$6.81B(+0.6%)
Dec 2010
$6.77B(+6.3%)
$1.53B(-12.8%)
$6.77B(+3.0%)
Sep 2010
-
$1.75B(-1.7%)
$6.58B(+1.0%)
Jun 2010
-
$1.78B(+4.3%)
$6.51B(+2.9%)
Mar 2010
-
$1.71B(+28.3%)
$6.33B(-0.7%)
Dec 2009
$6.37B(+15.2%)
$1.33B(-21.0%)
$6.37B(-2.7%)
Sep 2009
-
$1.69B(+5.6%)
$6.55B(+3.7%)
Jun 2009
-
$1.60B(-9.0%)
$6.31B(+5.0%)
Mar 2009
-
$1.75B(+16.2%)
$6.01B(+8.8%)
Dec 2008
$5.53B(+15.1%)
$1.51B(+3.9%)
$5.53B(+5.8%)
Sep 2008
-
$1.45B(+11.9%)
$5.23B(+4.9%)
Jun 2008
-
$1.30B(+2.3%)
$4.98B(+0.9%)
Mar 2008
-
$1.27B(+5.1%)
$4.94B(+2.8%)
Dec 2007
$4.80B(+16.4%)
$1.21B(-0.2%)
$4.80B(+3.2%)
Sep 2007
-
$1.21B(-3.4%)
$4.65B(+3.6%)
Jun 2007
-
$1.25B(+10.6%)
$4.49B(+6.1%)
Mar 2007
-
$1.13B(+7.1%)
$4.23B(+2.6%)
Dec 2006
$4.13B(+13.1%)
$1.06B(+0.7%)
$4.13B(+1.9%)
Sep 2006
-
$1.05B(+5.7%)
$4.05B(+3.0%)
Jun 2006
-
$993.60M(-3.0%)
$3.93B(+2.8%)
Mar 2006
-
$1.02B(+4.4%)
$3.83B(+4.9%)
Dec 2005
$3.65B(-0.3%)
$981.40M(+5.1%)
$3.65B(+0.2%)
Sep 2005
-
$933.50M(+5.1%)
$3.64B(+2.0%)
Jun 2005
-
$887.90M(+5.0%)
$3.57B(-0.5%)
Mar 2005
-
$845.80M(-13.2%)
$3.59B(-1.9%)
Dec 2004
$3.66B
$974.90M(+12.9%)
$3.66B(+2.4%)
Sep 2004
-
$863.60M(-4.6%)
$3.57B(-1.8%)
DateAnnualQuarterlyTTM
Jun 2004
-
$905.50M(-1.0%)
$3.64B(+1.3%)
Mar 2004
-
$914.70M(+2.8%)
$3.59B(+2.6%)
Dec 2003
$3.50B(+5.2%)
$889.80M(-4.2%)
$3.50B(-0.1%)
Sep 2003
-
$928.60M(+8.1%)
$3.50B(+1.0%)
Jun 2003
-
$859.40M(+4.3%)
$3.47B(+2.1%)
Mar 2003
-
$824.00M(-7.7%)
$3.40B(+2.2%)
Dec 2002
$3.33B(-10.8%)
$892.70M(-0.2%)
$3.33B(+3.2%)
Sep 2002
-
$894.50M(+13.3%)
$3.22B(+0.0%)
Jun 2002
-
$789.60M(+5.2%)
$3.22B(-7.4%)
Mar 2002
-
$750.90M(-4.9%)
$3.48B(-6.7%)
Dec 2001
$3.73B(+4.8%)
$789.60M(-11.6%)
$3.73B(-3.5%)
Sep 2001
-
$893.50M(-14.7%)
$3.86B(-3.1%)
Jun 2001
-
$1.05B(+4.9%)
$3.99B(+5.9%)
Mar 2001
-
$999.00M(+8.2%)
$3.76B(+5.7%)
Dec 2000
$3.56B(+5.8%)
$923.10M(-9.1%)
$3.56B(-1.3%)
Sep 2000
-
$1.02B(+23.0%)
$3.61B(+3.4%)
Jun 2000
-
$825.60M(+3.8%)
$3.49B(+2.5%)
Mar 2000
-
$795.60M(-17.9%)
$3.40B(+1.2%)
Dec 1999
$3.36B(+19.1%)
$969.50M(+8.0%)
$3.36B(+7.9%)
Sep 1999
-
$897.70M(+21.2%)
$3.12B(+4.8%)
Jun 1999
-
$740.40M(-2.1%)
$2.98B(+4.1%)
Mar 1999
-
$756.10M(+4.6%)
$2.86B(+1.2%)
Dec 1998
$2.82B(+15.8%)
$722.70M(-4.4%)
$2.82B(+3.8%)
Sep 1998
-
$756.20M(+21.5%)
$2.72B(+4.5%)
Jun 1998
-
$622.30M(-14.0%)
$2.60B(+3.2%)
Mar 1998
-
$723.30M(+16.8%)
$2.52B(+3.5%)
Dec 1997
$2.44B(+19.3%)
$619.40M(-3.2%)
$2.44B(+3.5%)
Sep 1997
-
$639.70M(+18.4%)
$2.36B(+4.5%)
Jun 1997
-
$540.50M(-15.4%)
$2.25B(+4.6%)
Mar 1997
-
$638.80M(+19.0%)
$2.15B(+5.4%)
Dec 1996
$2.04B(+3.2%)
$537.00M(-0.0%)
$2.04B(+4.2%)
Sep 1996
-
$537.20M(+21.9%)
$1.96B(+1.5%)
Jun 1996
-
$440.80M(-16.7%)
$1.93B(-0.9%)
Mar 1996
-
$529.30M(+16.4%)
$1.95B(-1.6%)
Dec 1995
$1.98B(+10.4%)
$454.80M(-10.4%)
$1.98B(+9.8%)
Sep 1995
-
$507.50M(+10.7%)
$1.81B(-0.9%)
Jun 1995
-
$458.60M(-18.2%)
$1.82B(-0.9%)
Mar 1995
-
$560.90M(+101.4%)
$1.84B(+2.4%)
Dec 1994
$1.79B(+175.0%)
$278.50M(-46.8%)
$1.79B(+126.9%)
Sep 1994
-
$523.50M(+10.2%)
$790.90M(+16.2%)
Jun 1994
-
$475.10M(-8.2%)
$680.50M(+2.8%)
Mar 1994
-
$517.80M(-171.4%)
$662.10M(+1.5%)
Dec 1993
$652.60M(-43.5%)
-$725.50M(-275.6%)
$652.60M(-64.2%)
Sep 1993
-
$413.10M(-9.5%)
$1.82B(+65.3%)
Jun 1993
-
$456.70M(-10.2%)
$1.10B(+1.8%)
Mar 1993
-
$508.30M(+14.1%)
$1.08B(-6.2%)
Dec 1992
$1.16B(-34.7%)
$445.30M(-244.9%)
$1.16B(+1.1%)
Sep 1992
-
-$307.40M(-170.3%)
$1.14B(-38.5%)
Jun 1992
-
$437.50M(-24.6%)
$1.86B(+0.4%)
Mar 1992
-
$580.10M(+33.9%)
$1.85B(+4.8%)
Dec 1991
$1.77B(+14.9%)
$433.20M(+5.9%)
$1.77B(+2.8%)
Sep 1991
-
$409.00M(-5.0%)
$1.72B(+2.5%)
Jun 1991
-
$430.30M(-13.2%)
$1.68B(+4.5%)
Mar 1991
-
$495.80M(+28.7%)
$1.61B(+4.3%)
Dec 1990
$1.54B(+32.2%)
$385.30M(+5.2%)
$1.54B(+12.7%)
Sep 1990
-
$366.40M(+2.5%)
$1.37B(+9.2%)
Jun 1990
-
$357.60M(-16.9%)
$1.25B(+4.7%)
Mar 1990
-
$430.10M(+103.5%)
$1.19B(-40.0%)
Dec 1989
$1.16B(+11.3%)
$211.30M(-15.9%)
$1.99B(-1077.6%)
Sep 1989
-
$251.20M(-16.5%)
-$203.40M(-141.9%)
Jun 1989
-
$301.00M(-75.4%)
$486.00M(-59.5%)
Mar 1989
-
$1.23B(-161.8%)
$1.20B(+14.6%)
Dec 1988
$1.05B(+75.9%)
-$1.98B(-310.6%)
$1.05B(+78.0%)
Sep 1988
-
$940.60M(-7.3%)
$588.10M(-2.8%)
Jun 1988
-
$1.01B(-5.4%)
$605.20M(-0.5%)
Mar 1988
-
$1.07B(-144.0%)
$608.10M(+2.2%)
Dec 1987
$595.00M(-30.8%)
-$2.44B(-354.7%)
$595.00M(-48.0%)
Sep 1987
-
$957.70M(-5.9%)
$1.14B(+6.9%)
Jun 1987
-
$1.02B(-3.9%)
$1.07B(+14.9%)
Mar 1987
-
$1.06B(-156.0%)
$931.00M(+8.2%)
Dec 1986
$860.30M(+12.5%)
-$1.89B(-314.0%)
$860.30M(-19.0%)
Sep 1986
-
$883.40M(+0.5%)
$1.06B(+9.9%)
Jun 1986
-
$879.30M(-11.0%)
$966.30M(+14.5%)
Mar 1986
-
$988.30M(-158.5%)
$843.80M(+10.4%)
Dec 1985
$764.40M(+2.7%)
-$1.69B(-314.4%)
$764.30M(-11.8%)
Sep 1985
-
$787.90M(+4.1%)
$866.50M(+9.5%)
Jun 1985
-
$756.80M(-16.7%)
$791.20M(+4.3%)
Mar 1985
-
$908.80M(-157.3%)
$758.30M(+1.9%)
Dec 1984
$744.30M
-$1.59B(-322.7%)
$744.30M(-68.1%)
Sep 1984
-
$712.60M(-1.6%)
$2.33B(+44.0%)
Jun 1984
-
$723.90M(-19.1%)
$1.62B(+80.9%)
Mar 1984
-
$894.80M
$894.80M

FAQ

  • What is Eli Lilly and Company annual operating income?
  • What is the all time high annual operating profit for Eli Lilly and Company?
  • What is Eli Lilly and Company annual operating profit year-on-year change?
  • What is Eli Lilly and Company quarterly operating income?
  • What is the all time high quarterly operating profit for Eli Lilly and Company?
  • What is Eli Lilly and Company quarterly operating profit year-on-year change?
  • What is Eli Lilly and Company TTM operating income?
  • What is the all time high TTM operating profit for Eli Lilly and Company?
  • What is Eli Lilly and Company TTM operating profit year-on-year change?

What is Eli Lilly and Company annual operating income?

The current annual operating profit of LLY is $17.04B

What is the all time high annual operating profit for Eli Lilly and Company?

Eli Lilly and Company all-time high annual operating income is $17.04B

What is Eli Lilly and Company annual operating profit year-on-year change?

Over the past year, LLY annual operating income has changed by +$6.25B (+57.96%)

What is Eli Lilly and Company quarterly operating income?

The current quarterly operating profit of LLY is $5.68B

What is the all time high quarterly operating profit for Eli Lilly and Company?

Eli Lilly and Company all-time high quarterly operating income is $5.68B

What is Eli Lilly and Company quarterly operating profit year-on-year change?

Over the past year, LLY quarterly operating income has changed by $0.00 (0.00%)

What is Eli Lilly and Company TTM operating income?

The current TTM operating profit of LLY is $17.27B

What is the all time high TTM operating profit for Eli Lilly and Company?

Eli Lilly and Company all-time high TTM operating income is $17.27B

What is Eli Lilly and Company TTM operating profit year-on-year change?

Over the past year, LLY TTM operating income has changed by $0.00 (0.00%)
On this page